NFSG Corp Boosts Stock Position in Tempus AI, Inc. $TEM

NFSG Corp grew its position in shares of Tempus AI, Inc. (NASDAQ:TEM) by 953.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,115 shares of the company’s stock after purchasing an additional 10,060 shares during the quarter. NFSG Corp’s holdings in Tempus AI were worth $503,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in Tempus AI in the third quarter worth approximately $26,000. Los Angeles Capital Management LLC bought a new position in Tempus AI during the fourth quarter valued at approximately $27,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Tempus AI during the third quarter worth approximately $38,000. Whittier Trust Co. raised its stake in shares of Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after acquiring an additional 570 shares in the last quarter. Finally, Lodestone Wealth Management LLC bought a new stake in shares of Tempus AI in the 4th quarter worth approximately $42,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on TEM. Wall Street Zen cut shares of Tempus AI from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. TD Cowen reiterated a “buy” rating on shares of Tempus AI in a research report on Wednesday. Jefferies Financial Group started coverage on shares of Tempus AI in a research note on Monday, April 13th. They issued an “underperform” rating and a $35.00 price target for the company. Wolfe Research started coverage on shares of Tempus AI in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Finally, Guggenheim reduced their price objective on Tempus AI from $95.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, March 30th. Nine investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $68.54.

Insider Activity

In other news, CFO James William Rogers sold 11,529 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $55.00, for a total transaction of $634,095.00. Following the completion of the transaction, the chief financial officer directly owned 114,866 shares of the company’s stock, valued at approximately $6,317,630. This represents a 9.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total value of $7,763,875.00. Following the completion of the sale, the chief executive officer directly owned 8,808,533 shares in the company, valued at $411,358,491.10. The trade was a 1.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 616,043 shares of company stock worth $31,748,593 over the last ninety days. 24.26% of the stock is owned by insiders.

Tempus AI Stock Down 2.4%

Shares of Tempus AI stock opened at $57.25 on Thursday. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. Tempus AI, Inc. has a 52-week low of $41.73 and a 52-week high of $104.32. The stock has a market capitalization of $10.28 billion, a price-to-earnings ratio of -33.28 and a beta of 3.46. The company’s 50 day moving average price is $51.46 and its 200-day moving average price is $54.12.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.08. The company had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The firm’s revenue for the quarter was up 36.1% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.24) earnings per share. Equities research analysts forecast that Tempus AI, Inc. will post -1.35 EPS for the current year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.